BIOPTIMATE ApS: Financial statements 2016
CVR: 36051183
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
BIOPTIMATE ApS (CVR 36051183) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK -12,720 and a net result of DKK 39,293. Equity in the 2016 report amounted to DKK 99,237. The solvency ratio was 82.4%.
- Gross Profit
- DKK -12,720
- Profit/Loss
- DKK 39,293
- Equity
- DKK 99,237
- Total Assets
- DKK 120,367
Find more companies like BIOPTIMATE ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
BIOPTIMATE ApS has published its interim report for the period July 18, 2014 – December 31, 2015.
As of July 5, 2016, RGH af 1. november 2024 A/S has been appointed auditor of BIOPTIMATE ApS.
As of July 5, 2016, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of BIOPTIMATE ApS.
About BIOPTIMATE ApS
BIOPTIMATE ApS is a Danish company of the type Anpartsselskab based in Birkerød, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Jens Christian Sørensen. The company is owned by Pure20 ApS. In 2025, the company reported a gross profit of DKK -1,252,436 and a net result of DKK -1,858,649 compared with DKK -6,367,118 the year before. Equity in the 2025 report amounted to DKK -5,714,314.